T cell immunity to herpes simplex viruses in seronegative subjects: Silent infection or acquired immunity?

Journal of Immunology

Volumn 170, Issue 8, 2003, Pages 4380-4388

  Posavad, Christine M ^a,b,d   Wald, Anna ^a   Hosken, Nancy ^c   Huang, Meei Li ^a   Koelle, David M ^a,b   Ashley, Rhoda L ^a   Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GLAXOSMITHKLINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HERPES VACCINE;

ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; BODY FLUID; CELL CLONE; CELL ISOLATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA DETERMINATION; EPITOPE MAPPING; GENITAL HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFECTION; MOUTH MUCOSA; PRIORITY JOURNAL; SAMPLING; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; VACCINE PRODUCTION; VIRUS DETECTION;

EID: 0037446668     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.8.4380     Document Type: Article

References (49)

1. Wald, A., A. G. M. Langenberg, K. Link, A. E. Izu, R. Ashley, T. Warren, S. Tyring, J. M. Douglas, and L. Corey. 2001. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 285:3100.
2. Corey, L., A. G. Langenberg, R. Ashley, R. E. Sekulovich, A. E. Izu, J. M. J. Douglas, H. H. Handsfield, T. Warren, L. Marr, S. Tyring, et al. 1999. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials: Chiron HSV Vaccine Study Group. JAMA 282:331.
3. Brown, Z. A., S. Selke, J. Zeh, J. Kopelman, A. Maslow, R. L. Ashley, H. Watts, S. Berry, M. Herd, and L. Corey. 1997. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337:509.
4. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H. N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012.
5. Langlade-Demoyen, P., N. Hgo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1293.
6. Pinto, L. A., J. Sullivan, J. A. Berzofsky, M. Clerici, H. A. Kessler, A. L. Landay, and G. M. Shearer. 1995. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:867.
7. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, et al. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
8. Rowland-Jones, S. L., T. Dong, L. Dorrell, G. Ogg, P. Hansasuta, P. Krausa, J. Kimani, S. Sabally, K. Ariyoshi, J. Oyugi, et al. 1999. Broadly cross-reactive HIV-specific cytotoxic T lymphocytes in highly-exposed persistently seronegative donors. Immunol. Lett. 66:9.
9. Bernard, N. F., C. M. Yannakis, J. S. Lee, and C. M. Tsoukas. 1999. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. J. Infect. Dis. 179:538.
10. Goh, W. C., J. Markee, R. E. Akridge, M. Meldorf, L. Musey, T. Karchmer, M. Krone, A. Collier, L. Corey, M. Emerman, et al. 1999. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J. Infect. Dis. 179:548.
11. Bienzle, D., K. S. MacDonald, F. M. Smaill, C. Kovacs, M. Baqi, B. Courssaris, M. A. Luscher, S. L. Walmsley, and K. L. Rosenthal. 2000. Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1 discordant partners. J. Infect. Dis. 182:123.
12. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J. Immunol. 164:1602.
13. Schmechel, S. C., N. Russell, F. Hladik, J. Lang, A. Wilson, R. Ha, A. Desbien, and M. J. McElrath. 2001. Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons. Immunol. Lett. 79:21.
14. + T cells in hepatitis C virus-exposed healthy seronegative donors. J. Immunol. 162:6681.
15. Koziel, M. J., D. K. H. Wong, D. Dudley, M. Houghton, and B. D. Walker. 1997. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J. Infect. Dis. 176:859.
16. + cytotoxic T cells from virus naive individuals. J. Immunol. 168:909.
17. Posavad, C. M., and K. L. Rosenthal. 1992. Herpes simplex virus-infected fibroblasts are resistant to and inhibit cytotoxic T-lymphoyte activity. J. Virol. 66:6264.
18. + cytotoxic T lymphocyte activity. Proc. Natl. Acad. Sci. USA 94:10289.
19. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:8165.
20. + T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J. Virol. 68:2803.
21. Asanuma, H., M. Sharp, H. T. Maecker, V. C. Maino, and A. M. Arvin 2000. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J. Infect. Dis. 181:859.
22. Li, C. R., P. D. Greenberg, M. J. Gilbert, J. M. Goodrich, and S. R. Riddell. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971.
23. + T cells. J. Exp. Med. 191:551.
24. + memory T cells. J. Exp. Med. 186:859.
25. Ashley, R. L., J. Militoni, F. Lee, A. Nahmias, and L. Corey. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26:662.
26. Dalessio, J., and R. Ashley. 1992. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 western immunoblot. J. Clin. Microbiol. 30:1005.
27. Wald, A., J. Zeh, S. Selke, R. L. Ashley, and L. Corey. 1995. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 333:770.
28. Wald, A., L. Corey, R. Cone, A. Hobson, G. Davis, and J. Zeh. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J. Clin. Invest. 99:1092.
29. Langenberg, A., R. Zbanyszek, J. Dragavon, R. Ashley, and L. Corey. 1988. Comparison of diploid fibroblasts and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J. Clin. Microbiol. 26:1772.
30. Lafferty, W. E., S. Krofft, M. Remington, R. Giddings, C. Winter, A. Cent, and L. Corey. 1987. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population. J. Clin. Microbiol. 25:323.
31. Ryncarz, A. J., J. Goddard, A. Wald, M. L. Huang, B. Roizman, and L. Corey. 1999. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J. Clin. Microbiol. 37:1941.
32. Jerome, K. R., M. L. Huang, A. Wald, S. Selke, and L. Corey. 2002. Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time polymerase chain reaction. J. Clin. Microbiol. 40:2609.
33. Wedemeyer, H., E. Mizukoshi, A. R. Davis, J. R. Bennink, and B. Rehermann. 2001. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75:11392.
34. + T cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J. Virol. 67:6259.
35. Hiemstra, H. S., N. C. Schloot, P. A. v. Veelen, S. J. M. Willemen, K. L. M. C. Franken, J. J. v. Rood, R. R. P. d. Vries, A. Chaudhuri, P. O. Behan, and J. W. Dijfhout. 2001. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA 98:3988.
36. Fleming, D. T., G. M. McQuillan, R. E. Johnson, A. J. Nahmias, S. O. Aral, F. K. Lee, and M. E. S. Louis. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105.
37. Wald, A., J. Zeh, S. Selke, T. Warren, A. J. Ryncarz, R. Ashley, J. N. Krieger, and L. Corey. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342:844.
38. Mertz, G. J., W. Schmidt, J. L. Jourden, M. E. Guinan, M. L. Remington, A. Fahnlander, C. Winter, K. K. Holmes, and L. Corey. 1985. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex. Trans. Dis. 12:33.
39. Coen, D. M., M. Kosz-Vnenchak, J. G. Jacobson, D. A. Leib, C. L. Bogard, P. A. Schaffer, K. L. Tyler, and D. M. Knipe. 1989. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86:4736.
40. Lekstrom-Himes, J. A., P. Hohman, T. Warren, A. Wald, J. Nam, T. Simonis, L. Corey, and S. E. Straus. 1999. Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infection. J. Infect. Dis. 179:1077.
41. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367.
42. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722.
43. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427.
44. Geraghty, R. J., C. Krummenacher, G. H. Cohen, R. J. Eisenberg, and P. G. Spear. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:1618.
45. Cocchi, F., L. Menotti, P. Mirandola, M. Lopez, and G. Campadelli-Fiume. 1998. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J. Virol. 72:9992.
46. Cocchi, F., M. Lopez, L. Menotti, M. Aoubala, P. Dubreuil, and G. Campadelli-Fiume. 1998. The V domain of herpesvirus Ig-like receptor (H1gR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc. Natl. Acad. Sci. USA 95:15700.
47. Eberle, F., P. Dubreuil, M. G. Mattei, E. Devilard, and M. Lopez. 1995. The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene 159:267.
48. Warner, M. S., R. J. Geraghty, W. M. Martinez, R. I. Montgomery, J. C. Whitbeck, R. Xu, R. J. Eisenberg, G. H. Cohen, and P. G. Spear. 1998. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246:179.
49. Struyf, F., C. M. Posavad, E. Keyaerts, M. V. Ranst, L. Corey, and P. G. Spear. 2002. Search for polymorphisms in the genes for herpes simplex virus entry mediators, HVEM, nectin-1 and nectin-2 in immune seronegative individuals. J. Infect. Dis. 185:36.